鱼油来源n-3多不饱和脂肪酸对老年人身体成分、肌肉力量与躯体功能的影响:一项随机双盲安慰剂对照试验的二次分析
该随机双盲安慰剂对照试验纳入200名老年人,随机接受每日4克鱼油胶囊(含1.34克EPA和1.07克DHA)或4克玉米油胶囊共6个月。结果显示鱼油组大腿围、总骨骼肌量、四肢骨骼肌量、握力和计时起走时间均显著改善,甘油三酯降低且高密度脂蛋白胆固醇升高。
要点
- 每日4克鱼油(EPA 1.34克+DHA 1.07克)6个月可改善老年人骨骼肌量和握力。
- 鱼油补充可缩短计时起走时间并降低甘油三酯、升高高密度脂蛋白胆固醇。
- 总胆固醇和低密度脂蛋白胆固醇未见显著改善。
核心结论
- 6个月鱼油来源n-3多不饱和脂肪酸补充可有益影响老年人身体成分、肌肉力量、躯体功能和血脂谱,可考虑用于肌少症一级预防策略。
研究设计与样本
- 随机双盲安慰剂对照试验的二次分析,纳入200名符合条件的老年人,随机分为每日4克鱼油胶囊组(含1.34克EPA和1.07克DHA)或每日4克玉米油胶囊组(EPA+DHA<0.05克),干预6个月。
主要发现
- 与对照组相比,鱼油组大腿围、总骨骼肌量和四肢骨骼肌量显著增加(交互时间×组效应P均<0.001),身高校正后差异仍显著。
- 鱼油组握力(交互时间×组效应P<0.001)和计时起走时间(交互时间×组效应P<0.001)均改善。
- 鱼油组血清甘油三酯显著降低(交互时间×组效应P=0.012),高密度脂蛋白胆固醇显著升高(交互时间×组效应P<0.001)。
- 总胆固醇(交互时间×组效应P=0.413)和低密度脂蛋白胆固醇(交互时间×组效应P=0.089)无显著改善。
关键数值与推荐
- 鱼油组每日补充4克鱼油胶囊,含1.34克EPA和1.07克DHA,干预6个月。
- 对照组每日4克玉米油胶囊,EPA+DHA<0.05克。
- 主要结局为身体成分、握力和计时起走时间的变化,次要结局为血脂谱变化。
临床怎么用
- 对老年人可考虑每日补充含1.34克EPA和1.07克DHA的鱼油制剂以改善骨骼肌量、握力和躯体功能。
- 鱼油补充同时有助于降低甘油三酯和升高高密度脂蛋白胆固醇。
- 该干预可作为肌少症一级预防策略的参考,但需结合个体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: the effects regarding n-3 polyunsaturated fatty acid (n-3 PUFA) supplementation on sarcopenia have been explored by several clinical trials. Nonetheless, the use of n-3 PUFA for improving body composition, muscle strength and physical performance in older people is conflicting. OBJECTIVES: our aim was to perform a randomised, double-blind, controlled trial to evaluate the effects of 6-month n-3 PUFA supplementation on body composition, muscle strength and physical performance in older Chinese people. METHODS: in this double-blind, placebo-controlled trial, 200 eligible subjects were randomly assigned to receive 4 g/day fish oil capsules (1.34 g eicosapentaenoic [EPA] + 1.07 docosahexaenoic [DHA]) or 4 g/day corn oil capsules (EPA + DHA <0.05 g) for 6 months. The primary outcomes were the changes of body composition, muscle strength (hand grip strength) and physical performance (Timed Up and Go time). Secondary outcomes were the changes in serum lipid profiles. RESULTS: compared with control group, fish oil-derived n-3 PUFA supplementation resulted in significant increases in thigh circumference (interaction time × group effect P < 0.001), total skeletal muscle mass (interaction time × group effect P < 0.001) and appendicular skeletal muscle mass (interaction time × group effect P < 0.001); the differences were still significant even after height correction. Muscle strength and physical performance including hand grip strength (interaction time × group effect P < 0.001) and Timed Up and Go time (interaction time × group effect P < 0.001) were also improved after a 6-month fish oil-derived n-3 PUFA intervention. In terms of serum lipid profiles, fish oil-derived n-3 PUFA supplementation could significantly reduce serum level of triglyceride (interaction time × group effect P = 0.012) and increase high density lipoprotein cholesterol (interaction time × group effect P < 0.001); while no significant improvement was found in serum concentrations of total cholesterol (interaction time × group effect P = 0.413) and low density lipoprotein cholesterol (interaction time × group effect P = 0.089). CONCLUSIONS: our present trial demonstrated that a 6-month fish oil-derived n-3 PUFA supplementation could beneficially affect the body composition, muscle strength, physical performance and serum lipid profiles in older people, which could be into considerations when making strategies aiming to the primary prevention of sarcopenia.
引用
- Xu D, Lu Y, Yang X, et al. Effects of fish oil-derived n-3 polyunsaturated fatty acid on body composition, muscle strength and physical performance in older people: a secondary analysis of a randomised, double-blind, placebo-controlled trial. Age Ageing. 2022. PMID: 36571774. doi:10.1093/ageing/afac274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。